Our study was strengthened by the relatively large sample of AA men–a group traditionally under-represented in research involving PSA measurements and more likely than other populations to experience disparities in prostate cancer aggressiveness and mortality. The gene discussed is KLK3; the disease is Familial prostate cancer.